| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/17/2023 | 3.78% | JP Morgan | $70 → $65 | Maintains | Neutral |
| 05/05/2023 | 51.68% | Citigroup | $90 → $95 | Maintains | Buy |
| 04/19/2023 | 11.77% | Goldman Sachs | $63 → $70 | Maintains | Sell |
| 04/18/2023 | 11.77% | Goldman Sachs | $63 → $70 | Maintains | Sell |
| 02/10/2023 | 43.7% | Citigroup | $80 → $90 | Maintains | Buy |
| 10/21/2022 | 11.77% | UBS | → $70 | Initiates Coverage On | → Buy |
| 08/22/2022 | 27.73% | Citigroup | $70 → $80 | Upgrades | Neutral → Buy |
| 05/05/2022 | 38.91% | SVB Leerink | $85 → $87 | Maintains | Outperform |
| 04/13/2022 | -4.2% | Goldman Sachs | $73 → $60 | Maintains | Sell |
| 02/14/2022 | 35.72% | SVB Leerink | $84 → $85 | Maintains | Outperform |
| 11/02/2021 | 43.7% | Wells Fargo | $85 → $90 | Maintains | Equal-Weight |
| 09/09/2021 | 59.67% | SVB Leerink | $90 → $100 | Maintains | Outperform |
| 08/03/2021 | 35.72% | Wells Fargo | $70 → $85 | Maintains | Equal-Weight |
| 06/18/2021 | 35.72% | SVB Leerink | $80 → $85 | Maintains | Outperform |
| 06/15/2021 | — | Cleveland Research | Upgrades | Neutral → Buy | |
| 02/05/2021 | -12.18% | Wells Fargo | → $55 | Downgrades | Overweight → Equal-Weight |
| 01/27/2021 | 11.77% | SVB Leerink | $50 → $70 | Maintains | Outperform |
| 11/16/2020 | — | Wolfe Research | Upgrades | Underperform → Peer Perform | |
| 08/04/2020 | -24.96% | Citigroup | $38 → $47 | Maintains | Neutral |
| 08/04/2020 | -20.17% | SVB Leerink | $45 → $50 | Maintains | Outperform |
| 07/20/2020 | -21.76% | B of A Securities | $43 → $49 | Maintains | Buy |
| 05/07/2020 | -39.33% | Citigroup | $40 → $38 | Maintains | Neutral |
| 05/07/2020 | -32.94% | Wells Fargo | $50 → $42 | Maintains | Overweight |
| 04/28/2020 | -34.54% | UBS | $53 → $41 | Maintains | Neutral |
| 04/02/2020 | -44.12% | Stifel | $52 → $35 | Maintains | Hold |
| 04/01/2020 | — | Needham | Downgrades | Strong Buy → Hold | |
| 03/26/2020 | -23.36% | Barclays | $52 → $48 | Upgrades | Equal-Weight → Overweight |
| 03/20/2020 | -36.13% | Citigroup | $52 → $40 | Maintains | Neutral |
| 02/19/2020 | 0.59% | Needham | $62 → $63 | Maintains | Strong Buy |
| 01/08/2020 | -4.2% | Wells Fargo | → $60 | Initiates Coverage On | → Overweight |
| 01/07/2020 | -16.97% | Citigroup | → $52 | Initiates Coverage On | → Buy |
| 11/15/2019 | -15.38% | Stifel | → $53 | Initiates Coverage On | → Hold |
| 09/26/2019 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 07/15/2019 | -23.36% | Goldman Sachs | $32 → $48 | Upgrades | Sell → Neutral |
| 05/03/2019 | — | SVB Leerink | Upgrades | Market Perform → Outperform | |
| 04/12/2019 | — | Deutsche Bank | Upgrades | → Buy | |
| 01/03/2019 | -37.73% | Needham | → $39 | Initiates Coverage On | → Strong Buy |
What is the target price for Bruker (BRKR)?
The latest price target for Bruker (NASDAQ: BRKR) was reported by JP Morgan on October 17, 2023. The analyst firm set a price target for $65.00 expecting BRKR to rise to within 12 months (a possible 3.78% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bruker (BRKR)?
The latest analyst rating for Bruker (NASDAQ: BRKR) was provided by JP Morgan, and Bruker maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Bruker (BRKR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bruker, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bruker was filed on October 17, 2023 so you should expect the next rating to be made available sometime around October 17, 2024.
Is the Analyst Rating Bruker (BRKR) correct?
While ratings are subjective and will change, the latest Bruker (BRKR) rating was a maintained with a price target of $70.00 to $65.00. The current price Bruker (BRKR) is trading at is $62.63, which is out of the analyst's predicted range.